Relax environment norms for export growth, say pharmaceutical firms

Pharmaceutical companies have asked for abolition of stringent environment norms and goods and service tax benefits to boost competitiveness and export.

According to the Pharmaceutical Export Promotion Council, domestic companies exported pharmaceuticals worth $ 17.2 billion in FY 18. Between April-July in FY 19 companies exported $5.9 billion worth medicines and exports grew 13.4 percent.